4.8 Article

Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist

期刊

SCIENCE
卷 330, 期 6007, 页码 1091-1095

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1197410

关键词

-

资金

  1. Protein Structure Initiative (PSI) [U54 GM074961, U54 GM094618]
  2. NIH Roadmap [P50 GM073197]
  3. NIH [R21 RR025336, GM075915]
  4. Pfizer
  5. National Institute on Drug Abuse [DA022413, MH54137, DA023694]
  6. National Science Foundation [IIS0308078]
  7. Science Foundation Ireland [02-IN1-B266]
  8. National Cancer Institute [Y1-CO-1020]
  9. National Institute of General Medical Sciences [Y1-GM-1104]

向作者/读者索取更多资源

Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain. The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small molecule D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops. On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are observed. Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R. This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据